PERLMAN SENDROMU: PRENATAL VE POSTNATAL BULGULAR

Yıl 2025, Cilt: 22 Sayı: 1, 135 - 138, 22.03.2025

Erdal Şeker , Mehmet Seçkin Özışık , Elvis Kraja , Yasemin Ezgi Köstekçi , Emel Okulu , Acar Koç

https://doi.org/10.38136/jgon.1144213

Öz

Perlman sendromu, polihidramnios, fetal aşırı büyüme, yüz dismorfizmi ve visseromegali ile karakterize ve otozomal resesif bir şekilde kalıtılan son derece nadir bir sendromdur. Burada, prenatal polihidramnios, fetal asit, nefromegali, korpus kallozum agenezisi ve koroid pleksus kisti öyküsü olan ve nefromegali, hepatomegali, kolestaz, kardiyomegali, kriptorşidizm, solunum sıkıntısı, hipoglisemi, genelleştirilmiş kas hipotansiyonu ile başvuran akraba ailelerinden doğan bir erkek bebeği sunuyoruz. Doğumdan sonra ve 6 aylıkken ilerleyici solunum dekompansasyonu nedeniyle öldü. DIS3L2 geninde homozigot varyant mutasyonu ile doğrulanan Perlman sendromu (#267000) teşhisi kondu.

Anahtar Kelimeler

PERLMAN SENDROMU, NEFROMEGALİ, POLİHİDRAMNİYOS, FETAL ASİT, DIS3L2 Gene

PERLMAN SYNDROME: PRENATAL EVIDENCE AND POSTNATAL CONFIRMED

Öz

Perlman syndrome is an extremely rare syndrome characterized by polyhydramnios, fetal overgrowth, facial dysmorphism and visceromegaly, and inherited in an autosomal recessive fashion. We here report a male infant born to consanguineous parents with prenatal history of polyhydramnios, fetal ascites, nephromegaly, corpus callosum agenesis and choroid plexus cysts, and presented with nephromegaly, hepatomegaly, cholestasis, cardiomegaly, cryptorchidism, respiratory distress, hypoglycemia, generalized muscle hypotonia after birth, and died due to progressive respiratory decompensation at the age of 6 months. He was diagnosed with Perlman syndrome (#267000) confirmed with a homozygous variant mutation in the DIS3L2 gene.

Anahtar Kelimeler

Perlman Syndrome, Nephromegaly, • Polyhydramnios, • Fetal Ascites, DIS3L2 Gene

Kaynakça

• 1. Astuti D, Morris MR, Cooper WN, Staals RH, Wake NC, Fews GA, et al. Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility. Nat Genet. 2012;44(3):277-84. DOI: 10.1038/ng.1071.
• 2. Katori K, Hirata K, Higa K, Shono S, Nitahara K. Anesthetic management of an infant with Perlman syndrome. Paediatr Anaesth. 2006;16(12):1289-90. DOI: 10.1111/j.1460-9592.2006.01986.x.
• 3. Morris MR, Astuti D, Maher ER. Perlman syndrome: overgrowth, Wilms tumor predisposition and DIS3L2. Am J Med Genet C Semin Med Genet. 2013;163C(2):106-13. DOI: 10.1002/ajmg.c.31358.
• 4. Higashimoto K, Maeda T, Okada J, Ohtsuka Y, Sasaki K, Hirose A, et al. Homozygous deletion of DIS3L2 exon 9 due to non-allelic homologous recombination between LINE-1s in a Japanese patient with Perlman syndrome. Eur J Hum Genet. 2013;21(11):1316-9. DOI: 10.1038/ejhg.2013.45.
• 5. Ferianec V, Bartova M. Beckwith-Wiedemann syndrome with overlapping Perlman syndrome manifestation. J Matern Fetal Neonatal Med. 2014;27(15):1607-9. DOI: 10.3109/14767058.2013.864633.
• 6. Liban E, Kozenitzky IL. Metanephric hamartomas and nephroblastomatosis in siblings. Cancer. 1970;25(4):885-8. DOI: 10.1002/1097-0142(197004)25:4<885::aid-cncr2820250420>3.0.co;2-#.
• 7. Perlman M. Perlman syndrome: familial renal dysplasia with Wilms tumor, fetal gigantism, and multiple congenital anomalies. Am J Med Genet. 1986;25(4):793-5. DOI: 10.1002/ajmg.1320250418.
• 8. Perlman M, Goldberg GM, Bar-Ziv J, Danovitch G. Renal hamartomas and nephroblastomatosis with fetal gigantism: a familial syndrome. J Pediatr. 1973;83(3):414-8. DOI: 10.1016/s0022-3476(73)80264-1.
• 9. Perlman M, Levin M, Wittels B. Syndrome of fetal gigantism, renal hamartomas, and nephroblastomatosis with Wilms' tumor. Cancer. 1975;35(4):1212-7. DOI: 10.1002/1097-0142(197504)35:4<1212::aid-cncr2820350427>3.0.co;2-2.
• 10. Neri G, Martini-Neri ME, Katz BE, Opitz JM. The Perlman syndrome: familial renal dysplasia with Wilms tumor, fetal gigantism and multiple congenital anomalies. Am J Med Genet. 1984;19(1):195-207. DOI: 10.1002/ajmg.1320190120.
• 11. Alessandri JL, Cuillier F, Ramful D, Ernould S, Robin S, de Napoli-Cocci S, et al. Perlman syndrome: report, prenatal findings and review. Am J Med Genet A. 2008;146A(19):2532-7. DOI: 10.1002/ajmg.a.32391.
• 12. Piccione M, Cecconi M, Giuffre M, Lo Curto M, Malacarne M, Piro E, et al. Perlman syndrome: clinical report and nine-year follow-up. Am J Med Genet A. 2005;139A(2):131-5. DOI: 10.1002/ajmg.a.30994.
• 13. Neri G. The Helena syndromes. Am J Med Genet A. 2006;140(19):2007-12. DOI: 10.1002/ajmg.a.31415.
• 14. DeRoche ME, Craffey A, Greenstein R, Borgida AF. Antenatal sonographic features of Perlman syndrome. J Ultrasound Med. 2004;23(4):561-4. DOI: 10.7863/jum.2004.23.4.561.
• 15. Demirel G, Oguz SS, Celik IH, Uras N, Erdeve O, Dilmen U. Rare clinical entity Perlman syndrome: is cholestasis a new finding? Congenit Anom (Kyoto). 2011;51(1):43-5. DOI: 10.1111/j.1741-4520.2010.00294.x.